Ed Cinca | Future Pharma

Future Pharma 2026

June 1 - 2 2026

Renaissance Seaport District, Boston, MA

Ed Cinca

VP GLP-1 Novo Nordisk, Inc.

As the Vice President of the GLP-1 Portfolio, Ed oversees the commercial success of a core portfolio of Novo Nordisk brands including Victoza, Ozempic, and future GLP-1 products. 

Over the course of his 15 year career at Novo Nordisk, Ed has held numerous sales and marketing positions within the commercial organization including: brand management and leadership across multiple brands and product launches in both diabetes and obesity, District Sales Manager, and VP of Sales Execution & Operations. Most recently Ed oversaw the launch of the Ozempic brand.

Prior to his career in pharma, Ed worked on Wall Street in real estate finance and as a consultant to large, institutional investment banks for fixed income products.

Ed earned a BS in Finance from Lehigh University, an MBA in Marketing and Finance from Fordham University, and a Certificate of Professional Development from The Wharton School of the University of Pennsylvania.


Check out the incredible speaker line-up to see who will be joining Ed.

Download The Latest Agenda